Directed Evolution of an Anti-prion Protein scFv Fragment to an Affinity of 1 pM and its Structural Interpretation-Reference-Cited by-同舟云学术

Directed Evolution of an Anti-prion Protein scFv Fragment to an Affinity of 1 pM and its Structural Interpretation

Published:2006-10 Issue:1 Volume:363 Page:75-97
ISSN:0022-2836
Container-title:Journal of Molecular Biology
language:en
Short-container-title:Journal of Molecular Biology

Author:

Luginbühl Béatrice,Kanyo Zoltan,Jones R. Mark,Fletterick Robert J.,Prusiner Stanley B.,Cohen Fred E.,Williamson R. Anthony,Burton Dennis R.,Plückthun Andreas

Publisher

Elsevier BV

Subject

Molecular Biology,Structural Biology

Reference60 articles.

1. Prion diseases of humans and animals: their causes and molecular basis;Collinge;Annu. Rev. Neurosci.,2001

2. Molecular neurology of prion disease;Collinge;J. Neurol. Neurosurg. Psychiatry,2005

3. Human prion diseases: molecular and clinical aspects;Glatzel;Arch. Neurol.,2005

4. Synthetic mammalian prions;Legname;Science,2004

5. Prions;Prusiner;Proc. Natl Acad. Sci. USA,1998

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A selection and optimization strategy for single-domain antibodies targeting the PHF6 linear peptide within the tau intrinsically disordered protein;Journal of Biological Chemistry;2024-04

2. Performance enhancement of the lateral flow immunoassay by use of composite nanoparticles as signal labels;TrAC Trends in Analytical Chemistry;2024-01

3. Strategy of selection and optimization of single domain antibodies targeting the PHF6 linear peptide within the Tau intrinsically disordered protein;2023-07-19

4. Emerging nanomaterials for improved biosensing;Measurement: Sensors;2021-08

5. Therapeutic implications of prion diseases;Biosafety and Health;2021-04